References
- Weiss JS, Current options for the topical treatment of acne vulgaris. Pediatr Dermatol (1997) 14: 480–8.
- Russell JR, Topical therapy for acne. Am Fam Physician (2000) 61: 357–65.
- Wilkin JK, Dewitt S, Treatment of rosacea. Topical clindamycin versus oral tetracycline. Int J Dermatol (1993) 32: 65–7.
- Weston WL, Morelli JG, Steroid rosacea in prepubertal children. Arch Pediatr Adolesc Med (2000) 154: 62–4.
- Eady EA, Cove JH, Topical antibiotic therapy: current status and future prospects. Drugs Exp Clin Res (1990) 16: 423–33.
- Fulton JE, Pablo G, Topical antibacterial therapy for acne. Arch Dermatol (1974) 110: 83–6.
- Toyoda M, Morohashi M, An overview of topical antibiotics for acne treatment. Dermatology (1998) 196: 130–4.
- Bernstein JE, Shalita AR, Topically applied erythromycin in inflammatory acne vulgaris. J Am Acad Dermatol (1980) 2: 318–21.
- Hellgren L, Vincent J, Topical erythromycin for acne vulgaris. Dermatologica (1980) 161: 409–14.
- Lesher JK, Chalker DK, Smith JG, et al, An evaluation of 2% erythromycin ointment in the topical therapy of acne vulgaris. J Am Acad Dermatol (1985) 12: 526–31.
- Mills OH, Kligman AM, Topically applied erythromycin in rosacea. Arch Dermatol (1976) 112: 553–4 [Letter].
- Fernandez-Obregon AC, Azithromycin for the treatment of acne. Int J Dermatol (2000) 39: 45–50.
- Fulton JE, Pablo G, Topical antibacterial therapy for acne. Arch Dermatol (1974) 110: 83–6.
- Code of Federal Regulations, Title 21 Food and Drugs, vol. 4. Food and Drug Administration, Department of Health and Human Services: Rockville, MD, 2001: Chapter I.
- Vadas EB, Stability of pharmaceutical products. In: Gennaro AR, Chase GD, Mardersosian AD, et al, eds. Remington’s Pharmaceutical Sciences, 18th edn. Mack Publishing Co: Easton, PA: 1990: 1504–12.
- Hirshmann JV, Topical antibiotics in dermatology. Arch Dermatol (1988) 124: 1691–700.